HOME › DRUGS › TELISOTUZUMAB VEDOTIN-TLLV
ACTIVE SUBSTANCE / INN

TELISOTUZUMAB VEDOTIN-TLLV

Brand name(s): EMRELIS
FDA LISTED
PRESCRIPTION
BLA761384
ACTIVE SUBSTANCE
Telisotuzumab Vedotin-Tllv
REGULATORS
FDA
SPONSORS / MAH
ABBVIE INC
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
EMRELISBLA761384ABBVIE INCPrescription

FULL INTELLIGENCE ON TELISOTUZUMAB VEDOTIN-TLLV

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →